Limerick BioPharma Inc. Names Jill Carroll to Serve as Vice President of Strategic Corporate Development
8/18/2010 10:58:39 AM
More...
|
Limerick BioPharma Inc. Announces Positive Phase 1b Data for LIM-0705 in Preventing Toxicities Associated with the Transplant Drug, Tacrolimus
7/28/2010 9:03:55 AM
More...
|
Limerick BioPharma Inc. Announces Positive Phase 1a Data for LIM-0705
3/10/2010 9:48:24 AM
More...
|
Limerick BioPharma Inc. Raises $15 Million in Series C Financing
7/15/2009 6:55:35 AM
More...
|
Limerick Neurosciences Announces Name Change to Limerick BioPharma
9/29/2008 8:39:53 AM
More...
|